Companhia Brasileira Stock Analysis, Valuation (NYSE:CBD)

Add to My Stocks
$21.85 $0.72 (3.19%) CBD stock closing price Feb 16, 2018 (Closing)
Watch Robo Advisor Video of CBD Stock Analysis
Companhia Brasileira
Updated on : Feb 16, 2018
previous close
CBD 21.9 (0%)
S&P 500 2732.2 (0%)
Closing Price On: Feb 16, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Sector :
5 Quarter Revenue
Revenue Growth
Compared to the industry
Long Term Growth
5 Year CAGR:
Operating Profit
Operating Margin:
Sector Average:
5 Quarter Net Profit
Net Margins
LTM Margin
Compared to the industry
Cash Flow
Operating cash flow:
Net Income:
PS Valuation
Recent Growth
Long Term Growth
Operating Margins
Net Margins
Cash Flow
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
Industry PS :
Sector:   Retail-Wholesale.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
Return on Equity:
Free Cash Flow Margin:
Double Tap To Exit Full Screen

Companhia Brasileira Stock Analysis

42 5 2

Take a look at Amigobulls Companhia Brasileira stock analysis video. This video puts forward our latest analysis highlighting the pros and cons for CBD stock.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

Companhia Brasileira de Distribuicao-ADR Stock Rating 2.1/5

Amigobulls CBD stock analysis takes into account various financial ratios like relative valuation, Companhia Brasileira revenue, growth and return on equity based on latest quarter 2017 Q3 financial statements. We also check Companhia Brasileira dividend performance. Companhia Brasileira valuation analysis is based on relative valuation multiples like PE ratio and price to sales ratio. Based on a company's historical fundamentals we arrive at Companhia Brasileira stock rating which is indicative of the company's financial performance.

Should you buy CBD stock?

  • The lower PS ratio 0.5 for CBD stock versus Retail-Supermarkets industry average of 0.8 is a positive for the company.

Should you sell CBD stock?

  • Companhia Brasileira revenue saw a decline of -25.8% YoY in 2017 Q3.
  • Revenue declined at a CAGR of -12.4% over the last 5 years.
  • Companhia Brasileira had an unimpressive average operating margin of 2.3% during the Last Twelve Months (LTM).
  • Companhia Brasileira's LTM Net margins were poor at 0.6%.
  • Companhia Brasileira has a low ROIC (Return on Invested Capital) of 4.2%.
  • The TTM ROE (Return On Equity) for Companhia Brasileira is not so attractive at 2.2%.
  • The company has negative Free Cash Flows (FCF), with a negative FCF margin of -9%.

Comments on this video and Companhia Brasileira stock

Amigobulls Companhia Brasileira stock analysis helps investors in understanding how the company's fundamentals have performed in the last few quarters. The fundamentals of a company are vital to identify long-term investment opportunities.

Companhia Brasileira revenue growth is an indicator of the demand for a company's products while profit margin is indicative of company's pricing power and pricing strategy. Technical analysis comes in handy to check whether the market sentiment is in line with the fundamental picture of the company.